It aims to explore the potential of new therapeutic approaches for retinal dystrophies, combining nanotechnology, regenerative medicine, stem cells, gene therapy, genomics, bioengineering, ophtogenetics and photonics. There will be basic and translational researchers and experts in these fields, in order to share innovative therapeutic opportunities, and especially in the exploration and discovery of possible synergies to generate new multidisciplinary collaborative research projects.